Thursday, March 24, 2011

South Carolina jury finds J&J falsely marketed Risperdal

GoUpstate.com is reporting that a South Carolina "jury decided that Johnson & Johnson and a subsidiary violated South Carolina’s Unfair Trade Practices Act, but the company will wait until damages are determined next month before it decides whether to appeal the jury’s decision.  Circuit Judge Roger Couch is scheduled to decide after hearings April 18-19 how much J&J will pay in penalties to the state related to the marketing of the antipsychotic drug Risperdal."

No comments:

Post a Comment